The impact of eligibility criteria on KRASG12C inhibitor trials in patients with NSCLC

Journal:

Journal of the National Cancer Institute

Published:

2025-08-22

DOI:

10.1093/jnci/djaf236

Affiliations:

6

Authors:

16

Go to article

Institutions	Authors	Share
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	10.000000 10.000000	0.63
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	3.000000	0.19
Cornell University, United States of America (USA)	3.000000	0.19

Interested in Oncology and Carcinogenesis?